Navigation Links
General Mills, NBC's The Biggest Loser and Feeding America Partner to Launch Pound For Pound Challenge
Date:1/5/2009

Initiative encourages Americans to lose weight, feed the hungry

MINNEAPOLIS, Jan. 5 /PRNewswire/ -- General Mills, NBC's The Biggest Loser and Feeding America today announced they are partnering to launch the Pound For Pound Challenge, an initiative that encourages Americans to lose weight and feed the hungry. For every pound dieters pledge to lose this new year, a pound of groceries will be delivered to a local food bank.

"More and more people need help getting food on the table in these troubling economic times, but the Pound For Pound Challenge is helping to meet the demand for donations in a big way," said Vicki B. Escarra, president and CEO, Feeding America. "By providing more food resources for Americans, individuals and families can spend their money on other equally important basic necessities like rent or mortgage, utilities and transportation."

While 130 million people are overweight in the United States, 35 million Americans are at risk of hunger. The new Pound For Pound Challenge gives Americans the opportunity to fight the hunger crisis and help families in their neighborhoods by simply pledging to lose weight and get healthy. People can simply visit www.PFPChallenge.com or www.biggestloser.com and enter their weight loss goals to join the Challenge.

"General Mills has a long-standing commitment to nutrition and wellness, and we're thrilled to support a cause that will not only provide hunger relief but also encourage Americans to get healthier," said John Haugen, vice president, Health and Wellness at General Mills. "By joining the Challenge, Americans are helping themselves while helping the one in eight Americans who struggle with hunger."

In addition to pledging to lose weight, Americans can donate directly at

SOURCE General Mills
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Second Harvest Heartland, Feeding America, General Mills, and The Biggest Loser Team to Help Community Lose Weight and Raise Funds to Feed the Hungry
2. Sutter Health Welcomes New General Counsel
3. Pennsylvania Attorney General Corbett Announces a Multi-State, $7 Million Settlement With Airborne Health, Inc., Over Charges of Deceptive Advertising
4. Helix BioPharma Reports on 2008 Annual General Meeting and Provides Corporate Update
5. ProAssurance Acquires Mid-Continent General Agency to Expand Ancillary Healthcare Insurance Business
6. Chicago Neurosurgeon, in Castle Connolly Top Doctor Database, Being Considered for U.S. Surgeon General
7. U.S. May Soon Face Shortage of General Surgeons
8. Mayo Clinic finds it generally safe to withdraw anti-seizure medication in children with epilepsy
9. New Tobacco Research Finds Minnesotas Latino Population Smoking Significantly Less than General Population
10. Levaquin is the Preferred Quinolone Among More Than Half of All General Medical-Surgical Hospitals in the United States
11. Motorola Extends the Delivery of Personalized Media Experiences to Hospital Group Generale De Sante
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10VAs Health System Top Employer for AARP 58061 1VAs Health System Top Employer for AARP 58061 2Historic gene therapy trial to treat Alzheimers disease underway at Georgetown 58056 1Historic gene therapy trial to treat Alzheimers disease underway at Georgetown 58056 2Journalists invited to Darwin Chicago 2009 conference Oct 29 31 10039 1